Peng Z - Search Results

1

HER2 discordance between paired primary gastric cancer and metastasis: a meta-analysis.

Peng Z, Zou J, Zhang X, Yang Y, Gao J, Li Y, Li Y, Shen L. Peng Z, et al. Chin J Cancer Res. 2015 Apr;27(2):163-71. doi: 10.3978/j.issn.1000-9604.2014.12.09. Chin J Cancer Res. 2015. PMID: 25937778 Free PMC article.

2

Association between GSTP1 Ile105Val polymorphism and oxaliplatin-induced neuropathy: a systematic review and meta-analysis.

Peng Z, Wang Q, Gao J, Ji Z, Yuan J, Tian Y, Shen L. Peng Z, et al. Cancer Chemother Pharmacol. 2013 Aug;72(2):305-14. doi: 10.1007/s00280-013-2194-x. Epub 2013 May 22. Cancer Chemother Pharmacol. 2013. PMID: 23695028 Review.

3

Associations between UGT1A1*6/*28 polymorphisms and irinotecan-induced severe toxicity in Chinese gastric or esophageal cancer patients.

Gao J, Zhou J, Li Y, Peng Z, Li Y, Wang X, Shen L. Gao J, et al. Among authors: peng z. Med Oncol. 2013;30(3):630. doi: 10.1007/s12032-013-0630-8. Epub 2013 Jun 20. Med Oncol. 2013. PMID: 23783485

4

Prognostic significance of MET amplification and expression in gastric cancer: a systematic review with meta-analysis.

Peng Z, Zhu Y, Wang Q, Gao J, Li Y, Li Y, Ge S, Shen L. Peng Z, et al. PLoS One. 2014 Jan 8;9(1):e84502. doi: 10.1371/journal.pone.0084502. eCollection 2014. PLoS One. 2014. PMID: 24416238 Free PMC article. Review.

5

Axitinib alone or in combination with chemotherapeutic drugs exerts potent antitumor activity against human gastric cancer cells in vitro and in vivo.

He Q, Gao J, Ge S, Wang T, Li Y, Peng Z, Li Y, Shen L. He Q, et al. Among authors: peng z. J Cancer Res Clin Oncol. 2014 Sep;140(9):1575-83. doi: 10.1007/s00432-014-1693-4. Epub 2014 May 8. J Cancer Res Clin Oncol. 2014. PMID: 24804814

6

Serum HER2 extracellular domain as a potential alternative for tissue HER2 status in metastatic gastric cancer patients.

Peng Z, Liu Y, Li Y, Zhang X, Zhou J, Lu M, Li Q, Shen L. Peng Z, et al. Biomark Med. 2014;8(5):663-70. doi: 10.2217/bmm.14.10. Biomark Med. 2014. PMID: 25123035

7

Expression and clinical significance of c-Met in advanced esophageal squamous cell carcinoma.

Xu Y, Peng Z, Li Z, Lu M, Gao J, Li Y, Li Y, Shen L. Xu Y, et al. Among authors: peng z. BMC Cancer. 2015 Jan 15;15:6. doi: 10.1186/s12885-014-1001-3. BMC Cancer. 2015. PMID: 25588551 Free PMC article.

8

Predictive value of serum HER2 ECD in patients with HER2-positive advanced gastric cancer treated with trastuzumab plus chemotherapy.

Zhou J, Peng Z, Liu Y, Gong J, Zhang X, Lu M, Gao J, Li Y, Li Y, Shen L. Zhou J, et al. Among authors: peng z. J Gastroenterol. 2015 Sep;50(9):955-61. doi: 10.1007/s00535-015-1046-3. Epub 2015 Feb 22. J Gastroenterol. 2015. PMID: 25702260

9

Tumor MET Expression and Gene Amplification in Chinese Patients with Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer.

Peng Z, Li Z, Gao J, Lu M, Gong J, Tang ET, Oliner KS, Hei YJ, Zhou H, Shen L. Peng Z, et al. Mol Cancer Ther. 2015 Nov;14(11):2634-41. doi: 10.1158/1535-7163.MCT-15-0108. Epub 2015 Sep 1. Mol Cancer Ther. 2015. PMID: 26330547

10

Reply to the letter by Takeshi Yamada et al. concerning "Is serum HER2 ECD a predictive biomarker for response to trastuzumab in advanced gastric cancer?".

Zhou J, Peng Z, Shen L. Zhou J, et al. Among authors: peng z. J Gastroenterol. 2016 May;51(5):508. doi: 10.1007/s00535-016-1185-1. Epub 2016 Feb 20. J Gastroenterol. 2016. PMID: 26897738 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,020 results

Search Page

Filters